A Clinical Trial to Assess Subjects With Dry Eye Disease.

Completed · Phase 2

Conditions studied: Dry Eye

In brief

A Multi-Center Randomized, Double-Masked, Parallel Design, Vehicle-Controlled Phase 2 Clinical Trial to Assess the Efficacy and Safety of 0.25% Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects with Dry Eye Disease

Key facts

Study ID
NCT04971031
Run by
Aldeyra Therapeutics, Inc.
People needed
158
Starts
2021-06-15
Expected to finish
2021-09-08
Last updated by the study team
2025-02-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.